← Back to Search

Patient Advocate for Asthma (HAP2 Trial)

N/A
Waitlist Available
Led By Andrea J Apter, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

HAP2 Trial Summary

This trial will test the effectiveness of a Patient Advocate in maintaining communication between patient and provider and access to chronic care for adults with moderate or severe asthma recruited from clinics serving low-income urban neighborhoods.

Eligible Conditions
  • Asthma
  • Communication

HAP2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Asthma Control at One Year
Secondary outcome measures
Change in Asthma-related Quality of Life
Change in Emergency Department(ED) Visits at One Year
Change in Hospitalizations
+2 more

HAP2 Trial Design

2Treatment groups
Experimental Treatment
Group I: usual careExperimental Treatment1 Intervention
Patient receives asthma care as usual from their asthma provider
Group II: Patient advocateExperimental Treatment1 Intervention
Subject works with a Patient Advocate who coaches, models, and assists with preparations for a visit with the asthma doctor; attends the visit with permission of participant and provider; and confirms understanding. The PA facilitates scheduling, obtaining insurance coverage, overcoming patients' unique social and administrative barriers to carrying out medical advice, and transfer of information between providers and patients.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Advocate
2013
N/A
~320
Usual Care
1990
Completed Phase 4
~7700

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,002 Previous Clinical Trials
42,880,687 Total Patients Enrolled
10 Trials studying Asthma
1,899 Patients Enrolled for Asthma
Andrea J Apter, MDPrincipal InvestigatorUniversity of Pennsylvania

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Patient Advocate to Improve Real-world Asthma Management for Inner City Adults
Andrea Apter 2013. "A Patient Advocate to Improve Real-world Asthma Management for Inner City Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01972308.
~28 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top